IDSA releases updated coccidioidomycosis guidelines
No abstract available. Article truncated at 150 words. The Infectious Diseases Society of America (IDSA) has released updated Guidelines for the Treatment of Coccidioidomycosis, also known as cocci or Valley Fever (1). Coccidioidomycosis is a fungal infection endemic to the southwestern United State...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Arizona Thoracic Society
2016-09-01
|
Series: | Southwest Journal of Pulmonary and Critical Care |
Subjects: | |
Online Access: | http://www.swjpcc.com/news/2016/9/5/idsa-releases-updated-coccidioidomycosis-guidelines.html |
id |
doaj-31b557201b554dca9da292f56fc60316 |
---|---|
record_format |
Article |
spelling |
doaj-31b557201b554dca9da292f56fc603162020-11-25T00:04:39ZengArizona Thoracic SocietySouthwest Journal of Pulmonary and Critical Care2160-67732016-09-0113312512510.13175/swjpcc090-16IDSA releases updated coccidioidomycosis guidelinesRobbins RA0Phoenix Pulmonary and Critical Care Research and Education Foundation, Gilbert, AZ USANo abstract available. Article truncated at 150 words. The Infectious Diseases Society of America (IDSA) has released updated Guidelines for the Treatment of Coccidioidomycosis, also known as cocci or Valley Fever (1). Coccidioidomycosis is a fungal infection endemic to the southwestern United States and a common cause of pneumonia and pulmonary nodules in this area. However, the infection can disseminate systemically especially in immunocompromised hosts and certain ethnic populations resulting in a variety of pulmonary and extrapulmonary complications. In addition to recommendations for these complications, the new guidelines address management of special at-risk populations, preemptive management strategies in at-risk populations and after unintentional laboratory exposure. The guidelines also suggest shorter courses of antibiotics for hospitalized patients and more ambulatory treatment for most individuals who have contracted Valley Fever. The panel was led by John N. Galgiani, MD, director of the Valley Fever Center for Excellence at the University of Arizona Health Sciences. Galgiani led a panel of 16 ...http://www.swjpcc.com/news/2016/9/5/idsa-releases-updated-coccidioidomycosis-guidelines.htmlIDSAInfectious Diseases Society of Americaguidelinescoccidioidomycosiscocci. Valley FeverGalgiani JNValley Fever Center for Excellencetutorialmeningitisimmunocompromised |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Robbins RA |
spellingShingle |
Robbins RA IDSA releases updated coccidioidomycosis guidelines Southwest Journal of Pulmonary and Critical Care IDSA Infectious Diseases Society of America guidelines coccidioidomycosis cocci. Valley Fever Galgiani JN Valley Fever Center for Excellence tutorial meningitis immunocompromised |
author_facet |
Robbins RA |
author_sort |
Robbins RA |
title |
IDSA releases updated coccidioidomycosis guidelines |
title_short |
IDSA releases updated coccidioidomycosis guidelines |
title_full |
IDSA releases updated coccidioidomycosis guidelines |
title_fullStr |
IDSA releases updated coccidioidomycosis guidelines |
title_full_unstemmed |
IDSA releases updated coccidioidomycosis guidelines |
title_sort |
idsa releases updated coccidioidomycosis guidelines |
publisher |
Arizona Thoracic Society |
series |
Southwest Journal of Pulmonary and Critical Care |
issn |
2160-6773 |
publishDate |
2016-09-01 |
description |
No abstract available. Article truncated at 150 words. The Infectious Diseases Society of America (IDSA) has released updated Guidelines for the Treatment of Coccidioidomycosis, also known as cocci or Valley Fever (1). Coccidioidomycosis is a fungal infection endemic to the southwestern United States and a common cause of pneumonia and pulmonary nodules in this area. However, the infection can disseminate systemically especially in immunocompromised hosts and certain ethnic populations resulting in a variety of pulmonary and extrapulmonary complications. In addition to recommendations for these complications, the new guidelines address management of special at-risk populations, preemptive management strategies in at-risk populations and after unintentional laboratory exposure. The guidelines also suggest shorter courses of antibiotics for hospitalized patients and more ambulatory treatment for most individuals who have contracted Valley Fever. The panel was led by John N. Galgiani, MD, director of the Valley Fever Center for Excellence at the University of Arizona Health Sciences. Galgiani led a panel of 16 ... |
topic |
IDSA Infectious Diseases Society of America guidelines coccidioidomycosis cocci. Valley Fever Galgiani JN Valley Fever Center for Excellence tutorial meningitis immunocompromised |
url |
http://www.swjpcc.com/news/2016/9/5/idsa-releases-updated-coccidioidomycosis-guidelines.html |
work_keys_str_mv |
AT robbinsra idsareleasesupdatedcoccidioidomycosisguidelines |
_version_ |
1725428806913622016 |